192 Participants Needed

Care Navigation for Methamphetamine Addiction

(BEATMeth Trial)

AA
DR
Overseen ByDeborah Rinehart, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Denver Health and Hospital Authority
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

The overall goal of the study is to evaluate the effectiveness of a secondary prevention strategy implemented at a systems-level to prevent stimulant related overdoses.

Do I have to stop taking my current medications for the trial?

The trial protocol does not specify whether you need to stop taking your current medications.

What data supports the idea that Care Navigation for Methamphetamine Addiction is an effective treatment?

The available research shows that coordinating care for substance use disorders, like methamphetamine addiction, can lead to better health outcomes. For example, one study found that integrating behavioral health staff within primary care teams helps improve care transitions, which is important for effective treatment. Another study highlighted that people with substance use disorders, including methamphetamine users, benefit from accessing professional support services, especially when they face more severe use patterns and related harms. These findings suggest that Care Navigation, which involves coordinating different types of support, can be effective in helping people with methamphetamine addiction.12345

What safety data exists for Care Navigation in methamphetamine addiction treatment?

The provided research does not directly address safety data for Care Navigation or similar interventions like Care Coordination, Social Prescribing, or Active Signposting specifically for methamphetamine addiction. The studies focus on opioid use disorder treatments, medication-assisted treatments, and care coordination for substance use disorders in general, but do not provide specific safety data for the treatment of methamphetamine addiction using Care Navigation.24567

Is Care Navigation a promising treatment for methamphetamine addiction?

Yes, Care Navigation is a promising treatment for methamphetamine addiction. It helps people connect with health and support services, which can improve their chances of starting and staying in treatment. This approach is especially helpful for those who face challenges in accessing healthcare, as it provides guidance and support to meet their needs.1891011

Research Team

AA

Alia A Al-Tayyib, PhD

Principal Investigator

Denver Health

Eligibility Criteria

This trial is for adults over 18 who've had a meth-related health issue at Denver Health and haven't received substance use treatment there in the last 90 days. It's not for those planning to enter substance treatment soon, unable to interview in English, impaired, or under involuntary psychiatric/substance treatment orders.

Inclusion Criteria

You have had a methamphetamine-related incident while being enrolled in the Denver Health healthcare system.
I am 18 years old or older.

Exclusion Criteria

I cannot complete an interview in English.
I am able to understand and consent to participate in the study.
planning to enter substance treatment
See 3 more

Treatment Details

Interventions

  • Care Navigation
Trial OverviewThe study tests how well a new system-level strategy works to prevent overdoses related to stimulant use by providing care navigation services as an early intervention method.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Dedicated care navigator to address social support needs
Group II: Usual careActive Control1 Intervention
Standard of care.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Denver Health and Hospital Authority

Lead Sponsor

Trials
106
Recruited
403,000+

Centers for Disease Control and Prevention

Collaborator

Trials
902
Recruited
25,020,000+

Findings from Research

A study of 255 regular methamphetamine users in Melbourne over 12 months found that those with riskier use patterns, such as injecting, were more likely to seek professional support for their drug use.
General practitioners were the most frequently accessed source of support, highlighting the importance of healthcare providers in encouraging treatment initiation and addressing associated harms.
Factors associated with professional support access among a prospective cohort of methamphetamine users.Quinn, B., Stoové, M., Dietze, P.[2013]
Over the study period from 2010 to 2015, there was a modest increase of 5.6 percentage points in counties with access to opioid use disorder (OUD) prescribers, but as of 2015, 60% of US counties still lacked access to buprenorphine prescribers and over 75% lacked access to oral naltrexone prescribers.
Access to OUD treatment was primarily concentrated in urban areas, highlighting significant geographic and potential racial disparities, suggesting a need for targeted educational and training initiatives to improve access in underserved regions.
County-level access to opioid use disorder medications in medicare Part D (2010-2015).Abraham, AJ., Adams, GB., Bradford, AC., et al.[2021]
Separating addiction care from general medical care leads to poorer quality of medical treatment for patients with substance use issues, highlighting the need for better integration.
Strategies to improve care coordination include engaging patients in general medical settings, managing substance use disorders in primary care, incorporating family perspectives, and developing payment models that support integrated care.
A Research Agenda to Advance the Coordination of Care for General Medical and Substance Use Disorders.Quinn, AE., Rubinsky, AD., Fernandez, AC., et al.[2018]

References

Factors associated with professional support access among a prospective cohort of methamphetamine users. [2013]
County-level access to opioid use disorder medications in medicare Part D (2010-2015). [2021]
A Research Agenda to Advance the Coordination of Care for General Medical and Substance Use Disorders. [2018]
Mobile technology intervention to improve care coordination between HIV and substance use treatment providers: development, training, and evaluation protocol. [2018]
Managing care for patients with substance abuse disorders at community health centers. [2013]
Medication-assisted treatment for substance use disorders within a national community health center research network. [2018]
Comparison between buprenorphine provider availability and opioid deaths among US counties. [2019]
Unmet healthcare need among women who use methamphetamine in San Francisco. [2021]
Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial. [2022]
Five-year Changes in Methamphetamine Use, Dependence, and Remission in a Community-recruited Cohort. [2020]
Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature. [2023]